Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,084 public trials 2,045 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Clinical Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed With Mycosis Fungoides Cutaneous T-cell Lymphoma

NCT02296164

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Investigator Site Little Rock, Arkansas, United States
  • Investigator Site Duarte, California, United States
  • Investigator Site La Mesa, California, United States
  • Investigator Site San Francisco, California, United States
View all 36 locations
View Trial Details
Completed

Intrathecal Mafosfamide

NCT00062881

Conditions
Central Nervous System Neoplasms, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
Locations
  • Children'sHospital Los Angeles Los Angeles, California, United States
  • Children's Hospital National Medical Center Washington D.C., District of Columbia, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
View Trial Details
Completed

A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT01611090

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
Locations
  • Birmingham, Alabama, United States
  • Phoenix, Arizona, United States
  • Berkeley, California, United States
  • Duarte, California, United States
View all 155 locations
View Trial Details
Completed

A Multiple Ascending Dose Study of MEDI7247 in Patients With Selected Relapsed/Refractory Hematological Malignancies

NCT03106428

Conditions
Acute Myeloid Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +22 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Denver, Colorado, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Chicago, Illinois, United States
View all 14 locations
View Trial Details
Completed

Determining the Feasibility of MLN9708 as Maintenance After Allogeneic Stem Cell Transplant for Multiple Myeloma

NCT02168101

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Oncology Hematology Care Cincinnati, Ohio, United States
  • Tennessee Oncology PLLC Nashville, Tennessee, United States
  • Texas Transplant Institute San Antonio, Texas, United States
View Trial Details
Completed

A Study to Estimate the Effect Sizes of HRCT Endpoints in Response to Glucocorticoid Induction Therapy in Subjects With Pulmonary Sarcoidosis

NCT03324503

Conditions
Hemic and Lymphatic Diseases, Hypersensitivity, Hypersensitivity, Delayed, +8 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • University of Iowa Iowa City, Iowa, United States
  • Johns Hopkins University School of Medicine - Baltimore Baltimore, Maryland, United States
  • Pulmonary and Critical Care Medicine-Washington University School of Medicine St Louis, Missouri, United States
View all 20 locations
View Trial Details

Related conditions